nVerses Capital LLC Sells 900 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

nVerses Capital LLC decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 90.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 100 shares of the medical equipment provider’s stock after selling 900 shares during the period. nVerses Capital LLC’s holdings in Intuitive Surgical were worth $49,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in ISRG. Ullmann Wealth Partners Group LLC raised its stake in shares of Intuitive Surgical by 1.6% in the third quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock valued at $653,000 after acquiring an additional 21 shares during the period. One Wealth Management Investment & Advisory Services LLC raised its position in Intuitive Surgical by 3.4% in the 2nd quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock worth $310,000 after purchasing an additional 23 shares during the period. Daymark Wealth Partners LLC lifted its stake in Intuitive Surgical by 0.3% in the third quarter. Daymark Wealth Partners LLC now owns 7,027 shares of the medical equipment provider’s stock worth $3,452,000 after purchasing an additional 24 shares during the last quarter. Indiana Trust & Investment Management CO boosted its position in shares of Intuitive Surgical by 5.3% during the second quarter. Indiana Trust & Investment Management CO now owns 500 shares of the medical equipment provider’s stock valued at $222,000 after buying an additional 25 shares during the period. Finally, Hoxton Planning & Management LLC grew its stake in shares of Intuitive Surgical by 4.9% during the second quarter. Hoxton Planning & Management LLC now owns 534 shares of the medical equipment provider’s stock valued at $238,000 after buying an additional 25 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction on Monday, July 29th. The stock was sold at an average price of $446.60, for a total transaction of $167,921.60. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,458,979.60. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, Director Amal M. Johnson sold 2,943 shares of Intuitive Surgical stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $443.30, for a total transaction of $1,304,631.90. Following the completion of the sale, the director now directly owns 12,275 shares in the company, valued at approximately $5,441,507.50. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction on Monday, July 29th. The shares were sold at an average price of $446.60, for a total value of $167,921.60. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,458,979.60. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 48,902 shares of company stock worth $23,596,360 over the last three months. Corporate insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently issued reports on ISRG. Barclays boosted their price objective on Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a report on Thursday, July 18th. Wells Fargo & Company boosted their target price on shares of Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a research note on Friday, October 18th. Citigroup raised their price target on shares of Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Robert W. Baird boosted their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. Finally, Truist Financial raised their target price on shares of Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a research report on Monday, October 14th. One analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $513.74.

Intuitive Surgical Stock Performance

ISRG stock opened at $517.50 on Wednesday. The firm has a 50-day simple moving average of $485.88 and a two-hundred day simple moving average of $440.46. Intuitive Surgical, Inc. has a one year low of $254.85 and a one year high of $523.34. The firm has a market cap of $183.56 billion, a price-to-earnings ratio of 93.41, a PEG ratio of 5.40 and a beta of 1.39.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.